Clinical Trial Update: Venetoclax, Azacitidine and Liposomal Mitoxantrone for Newly Diagnosed AML [NA]

View source ↗

Summary

Clinical trial update for a newly diagnosed acute myeloid leukemia study combining venetoclax, azacitidine, and liposomal mitoxantrone; the trial is not yet rec…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Drugs mentioned

• Liposomal mitoxantrone (mitoxantrone)
• VIDAZA (AZACITIDINE)
• Venclexta (venetoclax)

Snippet

Sponsor: Institute of Hematology & Blood Diseases Hospital, China | Conditions: AML | NA | Status: NOT_YET_RECRUITING